What is Infervision?
Infervision leverages cutting-edge AI technology to enhance patient care by improving the detection and treatment of diseases. The company offers innovative solutions for hospitals and medical organizations, including advanced imaging systems like InferRead for various diagnostic applications and InferOperate for surgical planning and reconstruction. Infervision primarily serves radiologists, surgeons, researchers, and healthcare teams, aiming to optimize patient outcomes and streamline hospital operations. With a global presence in over 25 countries and a robust portfolio of patents and publications, Infervision is dedicated to seamless integration into existing medical workflows, driving advancements in the healthcare industry.
How much funding has Infervision raised?
Infervision has raised a total of $165M across 3 funding rounds:
Series A
$8M
Series B
$18M
Series D
$139M
Series A (2017): $8M, investors not publicly disclosed
Series B (2017): $18M led by Genesis Capital, Sequoia Capital China, and Qiming Venture Partners
Series D (2021): $139M supported by CCB Trust, Goldman Sachs, and Z-Park Fund
Key Investors in Infervision
Genesis Capital
Genesis Capital is an investment and merchant banking firm focused on key growth sectors, providing tailored solutions for strategic growth initiatives and value maximization.
Sequoia Capital China
Sequoia Capital China is a venture capital firm known for its long-term investment approach and active partnership with entrepreneurs to build market-leading companies across various stages.
Qiming Venture Partners
Qiming Venture Partners is a leading investment firm that backs entrepreneurs in China's technology and healthcare industries, focusing on innovation and growth.
What's next for Infervision?
The substantial enterprise-level investment Infervision has garnered signals a strategic push towards scaling its operations and further developing its AI-driven healthcare solutions. This significant backing is expected to fuel research and development, expand its market reach, and enhance its product offerings in advanced medical imaging and surgical planning. The company's focus on integrating AI into clinical workflows positions it for continued growth and leadership in the rapidly evolving MedTech landscape, potentially leading to further strategic partnerships and market penetration.
See full Infervision company page
